Archive - September 2018
Teva launches first-to-file generic Cialis
J&J bails on Geron cancer drug
Lilly’s snaps up Chugai’s experimental diabetes drug
Alexion adds to pipeline with $1.2bn Syntimmune buy
Janssen hands back rights to imetelstat
Theranexus takes Alzheimer’s drug combo into clinic
FDA accepts Allergan’s Vraylar for review
Draft NICE decision rejects Respreeza for incurable, genetic disorder
